Results 131 to 140 of about 17,093 (242)

Synthesis and Th1-immunostimulatory activity of α-galactosylceramide analogues bearing a halogen-containing or selenium-containing acyl chain.

Bioorganic & Medicinal Chemistry, 2016
Md Imran Hossain, S. Hanashima, Takuto Nomura, Sébastien Lethu, H. Tsuchikawa, M. Murata, Hiroki Kusaka, S. Kita, K. Maenaka   +8 more
semanticscholar   +1 more source

<i>In vivo</i> stimulation of natural killer T cells and downstream regulatory T cells to reduce acute graft-versus-host disease. [PDF]

Ann Transl Med
Sluyter R, McErlean G.
europepmc   +1 more source

Targeted Delivery of α-Galactosylceramide to CD8α+ Dendritic Cells Optimizes Type I NKT Cell–Based Antitumor Responses

Journal of Immunology, 2014
Elodie Macho-Fernandez, L. Cruz, Reem Ghinnagow, J. Fontaine, E. Bialecki, B. Frisch, F. Trottein, C. Faveeuw   +7 more
semanticscholar   +1 more source

Brain lipid profiles and oligodendrocyte gene expression show discordant responses to high-fat diet in Alzheimer's disease mice. [PDF]

Sci Rep
Kawade N, Komine O, Sobue A, Kakimi C, Tanaka M, Suganami T, Shimada M, Ogi T, Ikeda K, Horiuchi M, Watanabe S, Saito T, Yamanaka K.   +12 more
europepmc   +1 more source

Sphingolipids in Gaucher disease: a systematic review. [PDF]

Orphanet J Rare Dis
Lake A, Fuller M.
europepmc   +1 more source

Sulfatide Acts as a Regulatory Molecule Controlling β1 Integrin-STAT5 Signaling and BOLA2-Dependent Apoptotic Pathway in Breast Cancer Cells. [PDF]

Int J Mol Sci
Suchanski J, Woldanska W, Sciana A, Suchanska B, Moniakowski L.   +4 more
europepmc   +1 more source

How do different cell populations orchestrate myelin regeneration? [PDF]

Biochem Soc Trans
Grassi S, Prinetti A.
europepmc   +1 more source

Complete Response in Recurrent End-Stage Pancreatic Cancer After Combined Immune Cell Therapy of α-Galactosylceramide Dendritic Cell Vaccine Therapy, Wilms' Tumor 1 Dendritic Cell Vaccine and Natural Killer Cell Therapy. [PDF]

Cureus
Liu K, Nagai H, Kanai N, Yamahara K.
europepmc   +1 more source

A phase I clinical trial to evaluate the tolerability and safety of an allogeneic iPSC-derived iNKT cell and α-GalCer-pulsed autologous DC combination therapy for patients with recurrent and advanced head and neck cancer: A study protocol. [PDF]

PLoS One
Kurokawa T, Iinuma T, Ebisu H, Yanagidaira T, Inaba Y, Fujiwara T, Hattori Y, Fukazawa T, Aoki T, Koseki H, Hanaoka H, Hanazawa T, Motohashi S.   +12 more
europepmc   +1 more source

Farber disease: Understanding a fatal childhood disorder and dissecting ceramide biology [PDF]

, 2013
Farber S, Mark S. Sands
core   +2 more sources